中华内科杂志2023年6月第62卷第6期Chin J Intem Med,Jne2023.Val.62.No.6·597·标准与讨论·中国毛霉病临床诊疗专家共识(2022)中国医药教育协会真菌病专业委员会中国毛霉病专家共识工作组通信作者：李若瑜，北京大学第一医院皮肤性病科北京大学真菌和真菌病研究中心皮肤病分子诊断北京市重，点实验室国家皮肤与免疫疾病临床医学研究中心，北京100034,Email:mvcolab@126.com:刘正印，中国医学料学院北京协和医学院北京协和医院感染疾病科，北京100730，Email:zhengyinl@hotmail.com;黄晓军，北京大学人民医院北京大学血液病研究所造血干细胞移植北京市重点实验室国家血液疾病临床医学研究中心，北京l00044,Email:huangxiaojun(@bjmu.edu.cn【摘要】毛霉病是重要的侵袭性霉菌病，诊治困难，病死率高。为提高临床医生对毛霉病的诊治水平，中国医药教育协会真菌病专业委员会组织多学科专家共同编写此专家共识。本共识参考最新国际毛霉病诊疗指南，结合我国毛霉病发病特点和治疗需求，内容涵盖病原学、高危因素、临床类型、影像学表现、病原学诊断、临床诊断、治疗和预防8个方面，以供我国临床医生借鉴和参考。【关键词】毛霉菌病：中国：毛霉菌目：诊断：治疗：共识基金项目：国家重点研发计划(2020YF℃2005400)】Expert consensus on diagnosis and management ofmucormycosis in ChinaMedical Mycology Society ofChinese Medicine and Education Association,Chinese Mucormycosis ExpertConsensus GroupCorresponding authors:Li Ruoyu,Department of Dermatology and Venerology,Peking University FirstHospital,Research Center for Medical Mycology,Peking University,Beijing Key Laboratory of MolecularDiagnosis of Dermatoses,National Clinical Research Center for Skin and Immune Diseases,Beijing100034,China,Email:mycolab@126.com;Liu Zhengyin,Department of Infection Disease,Peking UnionMedical College Hospital,Chinese Academy of Medical Sciences Peking Union Medical College,Beijing100730,China,Email:zhengyinl@hotmail.com;Huang XiaoJun,Peking University People's Hospital,Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem CellTransplantation,National Clinical Research Center for Hematologic Disease,Beijing 100044,China,Email:huangxiaojun@bjmu.edu.cnAbstract Mucormycosis is an important invasive fungal disease that is difficult todiagnose and treat,and has a high mortality rate.To improve the diagnosis and treatment ofmucormycosis by clinicians,the Medical Mycology Society of Chinese Medicine and EducationAssociation engaged multidisciplinary experts to compile this expert consensus.This consensusrefers to the latest international guidelines for diagnosis and treatment of mucormycosis,combinedwith the characteristics and treatment needs of mucormycosis in China and covers the followingeight aspects to provide reference for Chinese clinicians:pathogenic agents,high-risk factors,clinicaltypes,imaging manifestations,etiological diagnosis,clinical diagnosis,treatment,and prevention.Key words]Mucormycosis;China;Mucorales;Diagnosis;Treatment;ConsensusFund program:National Key Research and Development Project(2020YFC2005400)D01:10.3760/cma.i.cnl12138-20220729-00557收稿日期2022-07-29本文编辑赵景辉引用本文：中国医药教有协会真菌病专业委员会，中国毛霉病专家共识工作组.中国毛霉病临床诊疗专家共识(2022)0].中华内科杂志，2023,62(6k597-605.D0L:10.3760/emaj.cml12138-20220729-00557.
